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The basis for specificity during many cell-mediated immune responses has
been substantially clarified . T lymphocytes express individualized or clonotypic
antigen-recognition molecules, termed Ti, which recognize epitopes presented
by class I and II products of the MHC (1-3) . Polymorphic determinants onMHC
products seem to serve directly as antigens in transplantation . MHC molecules
also act as restriction elements to present other foreignantigens such as infectious
agents and soluble proteins (4) .
In addition to specificity, a notable aspect of immune responsiveness is that
antigen be administered on a specialized accessory population termed dendritic
cells (reviewed in reference 5) . One response that is initiated by dendritic cells is
the development of CTL (6, 7) . Most CTL have the phenotype CD4-,CD8+ .
Early studies (8-10) described the amplifying role of Th cells (having the
CD4+CD8- phenotype) in the generation ofCD8+ CTL. The helper cells would
release lymphokines, particularly IL-2, which seemed essential for CTL devel-
opment . Recent studies (11-13) have indicated that CD8+ T cells can be stimu-
lated directly to become CTL and produce IL-2, i.e ., in the absence ofCD4+ T
cells . We have studied the cellular requirements for the direct activation ofCD8+
CTL . We report that dendritic cells are active accessory cells for this pathway.
Macrophages, which bear readily detectable class I alloantigen, do not initiate an
MLR from the CD8+ subset but serve as targets for the CTL that are induced
by dendritic cells. The initial response of isolated CD8+ lymphocytes to dendritic
cells is comparable in many respects to CD4+ cells, including the formation of
dendritic-T cell clusters and the release of IL-2 .
Materials and Methods
Mice.
￿
BALB/c x DBA/2 (CxD2 ; H-2 dxd)F,, C57BL/6 x DBA/2 (116132 ; H-2 bxd)F,,
B6 .H-2k, andC57BL/6 mice of both sexes, 6-12 wk old (The Trudeau Institute, Saranac
Lake, NY), were used with similar results .
Cells.
￿
Enriched populations of dendritic cells were isolated as a low-density, macro-
phage-depleted, spleen-adherent fraction as described (14). These fractions were >90%
irregularly shaped, Fc receptor-negative, la-rich, 33131 antigen-positive, dendritic cells
(7, 15).
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T lymphocytes were nylon-wool nonadherent spleen and lymph node suspensions that
were treated with anti-la mAb (clones 10-2.16, anti I-A'; 14-4-5S anti I-E"'; or B21-2
anti-la"; American Type Culture Collection [ATCC], Bethesda, MD)along with an mAb
to a T cell subset. The cells were treated at a final concentration of 10" leukocytes/ml
and 5.5% fresh rabbit serum (Pel-Freeze Biologicals, Rodgers, WI). The cytotoxic anti-
T cell antibodies were GK 1.5 (rat anti-mouse L3T4 or anti-CD4; reference 16), HO 2.2
(mouse anti-Lyt-2 or anti-CD8; reference 17), C3PO (mouse anti-Lyt-1 or anti-CD5 ;
reference 18). Rat mAb, also obtained from the ATCC, were used to monitorcell surface
antigens by indirect immunofluorescence. The mAb included 53-6.7 anti-CD8, 53-7 .3
anti-CD5, GK 1.5 anti-CD4, F448.1 anti-LFA-1, M1/70 anti-C3bi receptor, and 7D4
anti-IL-2-R. Cells were affixed to multiwell slides (Carlson Scientific, Peotone, IL) that
had been coated with 75 kg/ml poly-L-lysine in PBS and stained successively with
hybridoma culture supernatants followed by FITC mouse anti-rat Ig (No. 605-540; 2
wg/ml; Boehringer Mannheim Biochemicals, Indianapolis, IN). The CD8- and CD4- T
cell subsets were at least 80-90% CD4' or CD8' with <1% contamination by the subset
killed by the mAb. Thepurity of the responding subset was further verified by functional
experiments in which we found that the proliferating cells in the MLR were CD8+,CD4-
and that the response was not inhibited by anti-CD4 mAb (reference 12; see Results).
Peritoneal macrophages were obtained by lavage of normal or thioglycollate-elicited
mice. 1-d plastic adherent (>95% macrophages by cytology and expression of the F4/80
and M1/70 antigens; reference 19) resident and elicited macrophages were used as
stimulators with similar results. Peritoneal macrophages were also used as "Cr targets for
CTL assays as described (20). Briefly, macrophages from stimulator (allogeneic) or
responder (syngeneic) mouse strains were labeled with Na"Cr04 either fresh or after
culture in Teflon beakers. 5,000 macrophageswere plated in triplicate in round-bottomed
microtest wells. Graded doses of washed effector cellsfrom the MLR were added for 4 h,
and the supernatants were measured for "Cr-release. Spontaneous release was <20% of
total release in the presence of 0.1% SDS. Spleen adherent cells, which contain both
macrophages and dendritic cells, were prepared from total or low-density spleen popula-
tions (14) and cultured overnight. Macrophages were enriched by eliminating most
dendritic cells by treatment with 33D1 mAb and complement (7, 15).
Mixed Leukocyte Reactions.
￿
Graded dosesof irradiated (900 rad 117Cs) dendritic cells or
other leukocytes (see Results) were added to syngeneic and allogeneic T cell subsets in
flat-bottomed, microtest (6 mm) or macrotest (16 mm) wells. Microcultures contained 0.2
ml medium and 3 x 105 T cells, and macrocultures had 1 .0 ml medium and 3 x 106 T
cells. The medium was RPMI 1640 supplemented with 5% FCS, 20 ug/ml gentamicin
sulfate, and 5 x 10-5 M 2-ME.
Dendritic cells-T cell clusters were isolated from the MLR by velocity sedimentation
as described (21). The frequency of dendritic cells in the clusters was determined by using
dendritic cells that had been tagged with a nontoxic carbocyanine dye as described (22).
Isolated dendritic-T cell clusters were dissociated by pipetting before counting total and
dye-labeled cells in a hemocytometer.
Proliferation in the MLR was measured by adding ['H]TdR at 4 ACi/ml for 12-16 h
at the indicated times. CTL were assayed on "Cr-labeled macrophages as targets (see
above). T cell growth factor was assayed by adding graded doses of culture medium to
104 Con A-induced T blasts in a total volume of 100 ml medium and by measuring [6H]-
TdR uptake at 18-24 h (23). Growth factor activity was neutralized >80% by the S4B6
anti-IL-2 mAb, kindly provided by Dr. T. Mossman (24) and was used as a culture
supernatant at 10% vol/vol. S4B6 did not block murine rIL-4 (provided by Dr. T.
Mossman, DNAX, Palo Alto, CA) or human IL-2 (provided by Dr. S. Rudnick, Biogen,
Cambridge, MA).
Results
Comparison of the CD4' and CD8' Responses to Allogeneic Dendritic Cells.
￿
Both
CD4+ and CD8' T cell subsets proliferated vigorously when challenged with184
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FIGURE 1.
￿
CD4+(Lyt-2-) and CD8+(L3T4-) T cell responsesto enriched dendriticcells. (A
and B) The kinetics of the MLR as illustrated with 105 (A) and 104 (B) dendritic cells from
BALB/c x DBA/2 (CxD2; H-2d) mice stimulating Tcell subsets from B6.H-2kmice. (C and
D) Dose-response curves illustrated with dendritic cellsfrom C57BL/6 x DBA/2 (B6xD2 ; H-
2bxd) mice stimulating CxD2 T cells for 4 (A) or 5 (B) d.
allogeneic dendritic cells in the three strain combinations that were tested (Fig.
1). Only 103-10' dendritic cells were needed to induce a strong MLR in 3 x 105
CD8+ cells. CD8+ cells ceased responding at earlier time points than CD4+ cellsA
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FIGURE 2.
￿
Proliferationand IL-2 production during the response ofCD4+andCD8' subsets
to syngeneicand allogeneic stimulators. (A andB) Comparison of the proliferative response to
dendritic cells from B6.H-2k mice and T cells from syngeneic B6.H-2k or allogeneic CxD2
mice, at day 4(A) and 5 (B). (C andD) IL-2 in the medium of cultures from Fig. 2, A andB.
Growth factor activity in the dendritic-T cell-conditioned medium was assayed (50% vol/vol)
on 3 X 10' Con A blasts. Maximum values in the bioassay were 105 cpm. The growth factor
was likely to be IL-2 (see text).186)
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FIGURE 3 .
￿
Cell-surface markers of lymphocytes in the CD4' and CD8' MLRs . Leukocytes
were harvested at day 4 and applied to multiwell slides . The cells were exposed to mAb (anti-
CD4 or L3T4, GK1 .5 ; anti-CD8 or Lyt-2, 53-6.7 ;and anti-CD5 or Lyt-I, 53-7 .1) followed by
FITC-mouse anti-rat Ig . Phase-contrast and immunofluorescence micrographs (x 300) are
shown to indicate that most cells, including the lymphoblasts, in the CD8' MLR were
CD4-,CD8* and vice versa for the CD4' MLR. Notshownare stains with apanel of additional
mAb which indicated that the large lymphoblasts in bothMLRs were positive for Thy-1, LFA-
1, and IL-2-R antigens but negative formacrophage and Fc receptor antigens .
(Fig . 1) and did not exhibit a syngeneic MLR (Fig . 2), as noted previously (12) .
T cell growth factor activity was readily detected when allogeneic dendritic cells
ulated CD8' lymphocytes (Fig . 2, C and D) . This growth factor was likely to
be IL-2, since its activitywas totally blockedby an mAbS4B6 (24) that neutralized
IL-2 but not IL-4 (data not shown) .
Evidence that Residual CD4' T Cells Are Not Required
sponse .
￿
When cells from the CD8' MLR were examined by
fluorescence, most of the T cells, including the lymphoblasts, stained brightly
with anti-CD8 mAb and FITC-mouse anti-rat Ig, but not at all with anti-CD4
mAb (Fig . 3) . Many CD8' lymphoblasts stained weakly with anti-CD5 (Lyt-1)
mAb as well (Fig. 3) .
Functional criteria were used to rule out a contribution by low but significant
hers of residual CD4' cells . It is known that anti-CD4 or anti-la antibodies
block CD4' but not CD8' responses (12, 25) . This proved to be the case in our
cultures (Fig . 4) . Anti-CD4 (anti-L3T4) and anti-la antibodies only blocked the
CD4 MLR, while anti-CD8 (anti-Lyt-2) only blocked the CD8' response . Both
T cell subsets were inhibited by anti-LFA-1 antibodies, but not by a large panel
ofmAb to other dendritic and T cell surface antigens (Fig . 4, legend) .
Development and Assay of Cytolytic T Cells .
￿
In addition to proliferative re-
sponses, aliospecific lytic activity was evident in CD8' MLRs generated in the
presence ofanti-CD4 mAb (Table 1) . We conclude that dendritic cells can directly
stimulate the CD8+ subset to proliferate and differentiate .
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FIGURE 4.
￿
Effects of mAbon the CD4' andCD8' MLRs. Dendriticcells from B6.H-2kmice
were added to 3 X 105 CD4} or CD8' T cells from CxD2 mice in the presence of various
mAb that were obtained from the American Type Culture Collection and directed to the
determinants listed in the legend. The mAb were GK 1.5, anti-CD4 or anti-L3T4; 53-6.7,
anti-CD8 or anti-Lyt-2; FD441.8,anti-CD11b or anti-LFA-1; anda mixtureof anti-I-A and I-
E mAb, 10-2.16, and 14-4-5S. Hybridoma culture supernatants were added at 25% vol/vol,
which was two to five times thedose needed for optimal blocking (not shown). Several isotype-
matched mAb were also tested but produced no blocking (not shown), including: 53-7.3,anti-
CD5 or Lyt-1; B5-3, anti-Thy-1 ; 33D1, anti-DC; M1/70, anti-C3biR; M1/42, anti-H-2K;
M1/9.3,anti-leukocyte. Similar findings were made in four experiments.
Relative Efficacy of Dendritic Cells and Other Leukocytes as Stimulators.
￿
Other
leukocyte populations were tested as accessory cells for the initiation ofthe CD8'
MLR. The first approach was to selectively reduce the trace dendritic cell
component in heterogeneous populations. Spleen cells (^-60% B lymphocytes,
3% macrophages, and 0.3% dendritic cells) and spleen adherent cells (^-80%
macrophages and 10% dendritic cells) were treated with the mAb 33D1 and
complement (7, 15). This mAb does not block dendritic cell function; but in the
presence of complement, 33D1 selectively kills dendritic cells and eliminates
function in several primary responses (7, 26, 27). Selective lysis of dendritic cells
eliminated 80-95% of the stimulating activity for both CD4' or CD8' MLRs
(Fig. 5).
Whole spleen populations consistently were at least 10 times less effective in
stimulating the CD8' subset as the CD4+ subset. For example, at the standard
stimulator responder ratio of 1 :1 and an early time point (day 4), bulk spleen
triggered a proliferative response of 105 cpm in CD4' cells but only 104 cpm in188
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MLR cultures,each containing 4 x 10' dendriticcellsand 4 x 106 CD8` lymphocytes in 1 ml culture
medium, were run in triplicate. 25% vol/vol of GK 1.5 anti-CD4 culture supernatant was added to
blockany residual CD4+ function, as verified by runningcompanion CD4+ MLRs (see Fig. 4). At 96
h thecells were washed andadded in graded doses to 10' "Cr-labeled peritoneal macrophages from
stimulator or responder mouse strains (20). Specific lysis was measured at 4 h. Spontaneous 5'Cr
releasewas <20%. Lysis in the syngeneic MLRwas 0-5% (not shown).
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Development ofAllospeciffc CTL in the Dendritic Cell - CD8+ Lymphocyte MLR
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FIGURE 5.
￿
Dendritic cellsare themain stimulator of CD4+andCD8* MLRs. Heterogeneous
leukocytes (whole spleen suspensions, WS; or spleen adherent cells, SAC) from B6xD2 mice
were treated with no mAbandcomplement or 33D1 anti-dendritic cell mAbandcomplement,
washed, irradiated (900 rad), and added in graded doses to 3 x 105 CD4* (Lyt-2") or CD8*
(GK 1 .5- or L3T4-) lymphocytes from CxD2 mice. The MLRs were measured at 86-96 h.
Sincedendritic cells were a trace componentof both WS and SACpopulations, killingwas not
detectable by trypan blue exclusion. Nevertheless, the dose-response curves indicated that
most of the stimulatory function wasablated in this and two other experiments.
Exp.
MHC
Stimulator
(H-2) of:
Responder
51Cr
target
Percentspecific "Cr
releaseat E/T ratios of:
_30:1 _10:1 _3:1
1 H-2b x H-2d H-2d x H-2d H-2 6 x d 28 20 1 .6
H-2dxd 0 0 0
_15:1 _5:1 _1 .5:1
2 H-2b x H-2d H-2d x H-2d H-2 b x d 29 18 11
H-2 d x d 0.7 1 0.7
_50:1 _15:1 _5:1
3 H-2d x H-2d H-2k H-2 d x d 49 29 17
H-2 k 0 0 0Stimulators
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TABLE II
Relative Efficacy of Dendritic Cells andMacrophages asMLR Stimulators
Proliferative response to graded doses stimulator cells
erent cells
Dendritic cells
Peritoneal macrophages
CD8' responders
Spleen adherent cells
Dendritic cells
Peritoneal macrophages
plus 10' dendritic cells
plus 105 dendritic cells
plus 102 dendritic cells
189
Graded doses of B6X D2 F1 stimulators were added to 3 x 10 5 C x D2 FITcell subsets (Lyt-2' or
CD4't, top, and L3T4- or CD8+, bottom) . Proliferationwasmeasured at 112-120 h . Dendritic cells
were >10timesmore active as stimulators than spleen adherentcells(< 10% dendriticcells). Peritoneal
macrophages were not stimulatory but could inhibit the function of dendritic cells.
FIGURE 6 .
￿
Cluster formation during DC-stimulated MLR'. On the top are low-power views
oftheMLR' at 24 h in an inverted microscope . When dendritic cells were added to CD4+ or
CD8' lymphocytes, clusters were readily evident (arrows) . Clusters were not observed when
dendritic cells or respondingTlymphocytes were cultured separately,when CD8' lymphocytes
were challenged with syngeneic dendritic cells, or when allogeneic macrophages and B cells
were used as stimulator cells (not shown) . On thebottom areGiemsa stains of a representative
cluster isolated by velocity sedimentation at 24 h, cultured one more day, and sedimented
onto a glass slide . Note the large numbersof lymphoblasts, including some in mitosis (arrows) .
105 3X10' 1W 3x10' 10 5 3x10 2
25.4 67.5 32.0 3.7
87.6 186.5 232.0 164.1 43.6 9.4
0.9 1 .4 0.4 0.3
17 .8 39 .3 17.0 2.3
44 .7 61 .0 42.8 36.8 5 .7 1 .4
0.5 0.5 0.5 0.3
10.9 15 .5 24.8 33.2
12.6 19 .1 24.3 29.3
7.1 9.5 11.5 12.3190
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TABLE III
Dendritic Cells-T Clusters Are thePrincipal Site ofthe CD4' and CD8' MLRs
5 x 104 B6.H-2k DC were labeled with a carbocyanine dye (22) and addedto C X D2, H-2d, CD4',
or CD8' T cells (5 X 106 per culture) for 24 h. Cluster and noncluster fractions were isolated by
velocity sedimentation. Cell numbersand percentdendritic cells were countedon a hemocytometer.
Aliquots of 3 X 104 clustered cells, 1.5 X 105 nonclusters, or mixtures were replated in microwell
cultures, andproliferation was measured at the timesindicated.
CD8' cells (Fig. 5). The use of bulk stimulator populations would therefore make
it difficult to detect a CD8' MLR.
Enriched populations of dendritic cells were then compared with enriched
peritoneal macrophages as stimulators of the CD8' MLR. Resident and thiogly-
collate-elicited macrophages did not initiate an MLR (Table 1I). Higher doses
(10'-104) of macrophages could inhibit stimulation by dendritic cells (Table II).
We conclude that to generate responses from CD8' populations, transplantation
antigens are best administered by dendritic cells rather than other leukocytes .
ClusteringofDendritic Cells and Responding CD8' T Lymphocytes.
￿
An important
feature of immune responses is that the accessory dendritic cells cluster the
responding T lymphocytes for prolonged periods (one or more days). The
subsequent immune response develops from these cell clusters (21, reviewed in
reference 5). Other APCs, such as macrophages and B lymphocytes, bind to
sensitized but not resting CD4+ cells (21, 28). When CD4+ and CD8' MLRs
were induced by dendritic cells, comparable clustering was evident (Fig. 6, top).
If clusters were isolated at 20 h, and cultured another day, most of the clustered
lymphocytes were typical activated lymphoblasts (Fig. 6, bottom). Clustering was
not evident when CD4+ or CD8' lymphocytes were stimulated with allogeneic
lymphocytes or macrophages (not shown). Quantitative studies indicated that
most of the dendritic cells and 5-10% of the lymphocytes were clustered in 24
h (Table III). When cluster and noncluster fractions were returned to culture,
proliferation (Table 111) and cytolytic T cell formation (not shown) were enriched
in the clusters, which functioned at very low cell concentrations . In different
experiments, proliferation by clustered lymphocytes approached (Table III) or
equalled (not shown) the mixture of clusters and nonclusters. Therefore clusters
are the principal site for the CD8' MLR, and these clusters seem to be uniquely
induced by dendritic cells.
Parameter
Cluster
CD4' T cells
Noncluster Mix Cluster
CD8' Tcells
Noncluster Mix
Percent DC in each fraction 3.3 0 - 2.3 0 -
at 24 h
Number of cells in each fraction 0.25 2.7 - 0.13 1.8 -
at 24 h (x 10-6)
Proliferative response
(cpm X 10') at:
36-48 h 18.9 2.9 28.0 33.9 1.6 36.1
66-72 h 102.6 0.7 176.2 150.0 0.9 180.0
90-96h 151.0 0.4 284.4 48 .8 0.9 70.9
114-120 h 42.4 0.4 95.3 2.1 0.6 12.4INABA ET AL.
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Discussion
The observations in this paper reveal that a remarkably similar pathway leads
to the activation of isolated CD8+ and CD4+ T lymphocytes during responses to
foreign leukocytes. Transplantation antigens are "sensed" by T lymphocytes
when presented on lymphoid dendritic cells that efficiently bind and activate
CD8+ cells to become lymphoblasts with modest cytolytic activity. Dendritic-T
cell (CD4+ or CD8+) clusters do not form when antigensare presentedon foreign
macrophages and lymphocytes, so that it is possible that the presence ofantigen
is being ignored by the T cells. The clustering of dendritic and T cells may
require an antigen-independent binding mechanism that recently has been de-
scribed (28). Clustering could have several consequences. It could provide the
time required for products on two opposing cell surfaces, particularly MHC
molecules on the presenting cell and receptors on unprimed lymphocyte clones,
to align and interact. Clustering could also provide "second signals," that is
stimuli other than antigen, that are necessary for T cell activation .
In contrast to resting T cells, the sensitized T blast can bind and respond to
antigens on other presenting cells. This is illustrated by the data on allogeneic
peritoneal macrophages. Peritoneal macrophages express readily detectable lev-
els of the class I MHC products that are recognized by CD8+ cells. Expression
of macrophage class I antigens has been monitored using cytotoxicity and
alloantibodies (29) as well as binding and immunoprecipitation with monoclonal
reagents (19, 30). Macrophages do not stimulate the CD8+ subset, yet serve as
excellent targets for the CTL that are induced by dendritic cells (Tables I and
I1). Likewise, Con A-induced lymphoblasts do not stimulate an MLR (Metlay,
J., and R. Steinman, unpublished observations) but are standard target cells for
sensitized CTL. Therefore, immune recognition, as evidenced by APC-T cell
binding or T cell responsiveness, clearly differs with the state of the T lympho-
cyte. Unprimed and memory lymphocytes bind and respond to dendritic cells,
while primed Tblasts can interact with many types ofpresenting cells (28).
Ofsome interest is the fact that production of IL-2 is readily detected in the
dendritic-CD8+ MLR (Fig. 2). There has been a wide range of reported results
on the ability of CD8+ cells to make T cell growth factors, presumably IL-2.
Some studies fail to detect IL-2, others add anti-IL-2-R antibodies to reduce IL-
2 utilization (13), while others (31-33) readily detect the lymphokine. The results
of von Boehmer et al. (32) may be particularly relevant, since CD8+ T cells
frequently lose the capacity to release growth factor after prolonged growth in
culture. Another possibility is that a subset ofCD8' cells produces abundant IL-
2, and this subset requires dendritic cells to be activated. Examination of
individual CD8+ cells in dendritic-CD8+ clusters (Fig. 6), as by in situ hybridiza-
tion, may clarify the frequency of CD8+ cells that produce IL-2 initially. Recent
data (23) indicate that mitogens induce comparable levels of IL-2 mRNA in
primary CD4+ and CD8+ responses.
Where CD4' and CD8+ MLRs differ considerably is in the longevity of the
proliferative response (Fig. 1), as reported by Sprent and Schaefer (12). The fact
that newly formed CD8+ blasts can kill APCs may explain the different kinetics.
Lysis of APCs may also account for the observation that large numbers of
allogeneic stimulators must be applied when whole spleen is thesource ofantigen192
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(Fig. 5). In the CD4' MLR, the lymphoblasts that are sensitized in the first 3-4
d of culture can continue to respond to the excess of allogeneic macrophages
and B cells that remain in the culture (21) . In the CD8+ MLR, lymphoblasts are
induced, but additional rounds of proliferation will not occur if the presenting
cell is killed by the sensitized CTL . We had noted this previously when we
compared the restimulation requirements of Lyt-2- and Lyt-1- T blasts (refer-
ence 21 ; Table IV). The former responded vigorously to B cells, but the Lyt-1-
blasts killed the lymphocytes and did not respond at all.
While helper cells are not required for the initiation of CTL responses to
antigens on dendritic cells, helper cells may be critical for sustaining and ampli-
fying CTL responses after the presenting cells are killed. If we isolate CD8' T
blasts from the MLR at days 3 or 4, exogenous factors must be added to retain
and expand CTL activity in the ensuing 1-2 d of culture (our unpublished
observation). We find that these factors are abundant in the conditioned medium
of the CD4' MLR .
Of some interest is the role of dendritic cells in the primary response to viral
and tumor antigens on other cells. Are antigens on infected or malignant cells
presented directly to unprimed CD8' T lymphocytes or via a dendritic cell in
the host? A pathway of CD8' CTL activation, in which viral antigen is presented
on dendritic cells, represents a potential but unexplored resistance mechanism
for acquired immune deficiency syndrome in which functioning CD4' helper
cells are compromised, or for any agent in which determinants can be presented
in association with class I but not class II MHC products. Again it needs to be
shown that dendritic cells can present such antigens. For these reasons, the results
described in this report are being extended to human leukocyte cultures and to
the generation of virus-specific CTL.
Summary
Recent experiments (11-13) have shown that antigen-specific, CD8+,CD4- T
lymphocytes can be induced to proliferate and become killer cells in the absence
of a second population of "helper" CD8-,CD4+ cells. We have studied early
events in the activation of CD4' and CD8+ T cell subsets in the primary mixed
leukocyte reaction. Dendritic cells are a major if not essential accessory cell for
the activation of both subpopulations. Antigen-bearing macrophages fail to
stimulate unprimed CD8+ cells, but act as targets for the sensitized cytolytic
lymphocytes that are induced by dendritic cells. The initial proliferative response
is comparable for CD4' and CD8+ lymphocyte subsets. For both subpopulations,
dendritic cells efficiently cluster the responding lymphocytes on the first day and
induce the release of IL-2 . The data indicate that CD4' and CD8' lymphocytes
can be activated by a similar mechanism, and illustrate the special role ofdendritic
cells in the sensitization stage of cell-mediated immunity.
Receivedfor publication 25 March 1987.
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